28386 Federal Register / Vol. 63, No. 99 / Friday, May 22, 1998 / Notices

San Diego, California; DFO Partnership,

San Francisco, California; First Franklin

Financial Corporation, San Jose,

California; First Franklin Funding

Corporation, San Jose, California;

General Fidelity Life Insurance

Company, San Diego, California;

Security Pacific Capital Leasing

Corporation, San Francisco, California;

and Security Pacific Housing Services,

Inc., San Diego, California. The

nonbanking activities of the companies

to be acquired also are listed in the

notice and include extending credit and

servicing loans, pursuant to 12 CFR

225.28(b)(1); leasing personal and real

property, pursuant to 12 CFR

225.28(b)(3); operating a savings

association through Bank of America,

FSB, Portland, Oregon, pursuant to 12

CFR 225.28(b)(4)(ii); providing financial

and investment advisory services,

pursuant to 12 CFR 225.28(b)(6);

providing securities brokerage, riskless

principal, private placement, futures

commission merchant, and other agency

transactional services, pursuant to 12

CFR 225.28(b)(7); underwriting and

dealing in certain government

obligations and money market

instruments that state member banks

may underwrite or deal in, pursuant to

12 CFR 225.28(b)(8)(i); acting as

principal, agent, or broker in connection

with the sale of credit-related insurance,

pursuant to 12 CFR 225.28(b)(11)(i);

engaging in community development

activities, pursuant to 12 CFR

225.28(b)(12); providing data processing

and data transmission services,

pursuant to 12 CFR 225.28(b)(14); and

engaging in all activities that

BankAmerica currently is authorized by

Board Order to conduct. As part of the

proposed transaction, NationsBank

proposes to engage through

BancAmerica Robertson Stephens, San

Francisco, California, in underwriting

and dealing in all types of debt and

equity securities (other than interests in

open-end investment companies) to a

limited extent in accordance with

previous Board decisions. In addition,

NationsBank proposes to engage,

directly or indirectly through its

subsidiaries, in certain other activities

that the Board previously has approved

by Order, including providing

administrative services to open-end and

closed-end investment companies.

In connection with the proposed

transaction, NationsBank also has

applied to acquire an option to purchase

up to 19.9 percent of the outstanding

shares of BankAmerica’s common stock.

BankAmerica also has applied to

acquire an option to purchase up to 19.9

percent of the outstanding shares of

NationsBank Corporation’s common

stock. These options would expire upon

consummation of the merger. Comments

regarding this application must be

received not later than June 24, 1998.

B. Federal Reserve Bank of Chicago

(Philip Jackson, Applications Officer)

230 South LaSalle Street, Chicago,

Illinois 60690-1413:

1. Associated Banc-Corp, Green Bay,

Wisconsin; to merge with Citizens

Bankshares, Inc., Shawano, Wisconsin,

and thereby indirectly acquire Citizens

Bank, National Association, Shawano,

Wisconsin.

In connection with this application,

Applicant also has applied to acquire

Wisconsin Finance Corporation,

Shawano, Wisconsin, and thereby

indirectly acquire Citizens Financial

Services, Inc., Shawano, Wisconsin, and

thereby engage in extending credit and

servicing loans and acting as principal,

agent, or broker for credit related

insurance, pursuant to §§ 225.28(b)(1)

and 225.28(b)(11)(ii) of the Board’s

Regulation Y.

2. West Burlington Bancorporation,

Inc., West Burlington, Iowa; to become

a bank holding company by acquiring

100 percent of the voting shares of West

Burlington Bank, West Burlington, Iowa.

C. Federal Reserve Bank of

Minneapolis (Karen L. Grandstrand,

Vice President) 90 Hennepin Avenue,

P.O. Box 291, Minneapolis, Minnesota

55480-0291:

1. M.I.F. Limited, Chisholm,

Minnesota; to become a bank holding

company by acquiring 100 percent of

the voting shares of Chisholm

Bancshares, Inc., Chisholm, Minnesota,

and thereby indirectly acquire First

National Bank, Chisholm, Minnesota.

2. Norwest Corporation, Minneapolis,

Minnesota; to acquire 100 percent of the

voting shares of First Bancshares, of

Valley City, Inc., Valley City, North

Dakota, and thereby indirectly acquire

First State Bank of Casselton, Casselton,

North Dakota; Litchville State Bank,

Litchville, North Dakota; and First

National Bank of Valley City, Valley

City, North Dakota.

In connection with this application,

Applicant also has applied to acquire

Peoples Insurance Agency, Inc., Valley

City, North Dakota, and thereby engage

in general insurance agency activities,

pursuant to § 225.28(b)(1)(vii) of the

Board’s Regulation Y.

3. Norwest Corporation, Minneapolis,

Minnesota; to acquire 100 percent of the

voting shares of Little Mountain

Bancshares, Inc., Monticello, Minnesota,

and thereby indirectly acquire First

National Bank of Monticello,

Monticello, Minnesota.

In connection with this application,

Applicant proposes to transfer the

mortgage origination and servicing

business of the First National Bank of

Monticello to its wholly owned

subsidiary, Norwest Mortgage, Inc., Des

Moines, Iowa. Norwest Mortgage Inc.,

proposes to engage in these activities,

pursuant to § 225.28(b)(1) of the Board’s

Regulation Y.

D. Federal Reserve Bank of San

Francisco (Maria Villanueva, Manager

of Analytical Support, Consumer

Regulation Group) 101 Market Street,

San Francisco, California 94105-1579:

1. UCBH Holdings, Inc., San

Francisco, California; to become a bank

holding company by acquiring 100

percent of the voting shares of United

Commercial Bank, F.S.B., San

Francisco, California. United

Commercial Bank, F.S.B., will convert

to a bank charter.

Board of Governors of the Federal Reserve

System, May 19, 1998.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 98–13790 Filed 5–21–98; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL RESERVE SYSTEM

Notice of Proposals to Engage in

Permissible Nonbanking Activities or

to Acquire Companies that are

Engaged in Permissible Nonbanking

Activities

The companies listed in this notice

have given notice under section 4 of the

Bank Holding Company Act (12 U.S.C.

1843) (BHC Act) and Regulation Y, (12

CFR Part 225) to engage de novo, or to

acquire or control voting securities or

assets of a company, including the

companies listed below, that engages

either directly or through a subsidiary or

other company, in a nonbanking activity

that is listed in § 225.28 of Regulation

Y (12 CFR 225.28) or that the Board has

determined by Order to be closely

related to banking and permissible for

bank holding companies. Unless

otherwise noted, these activities will be

conducted throughout the United States.

Each notice is available for inspection

at the Federal Reserve Bank indicated.

The notice also will be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing on the

question whether the proposal complies

with the standards of section 4 of the

BHC Act.

Unless otherwise noted, comments

regarding the applications must be

received at the Reserve Bank indicated
Federal Register / Vol. 63, No. 99 / Friday, May 22, 1998 / Notices 28387

or the offices of the Board of Governors

not later than June 9, 1998.

A. Federal Reserve Bank of

Philadelphia (Michael E. Collins, Senior

Vice President) 100 North 6th Street,

Philadelphia, Pennsylvania 19105-1521:

1. Commerce Bancorp, Cherry Hill,

Pennsylvania; to acquire Commerce

Capital, Philadelphia, Pennsylvania,

and thereby engage in Tier II securities

underwriting and dealing and related

activites, including bonds issued by notfor-profit entities that qualify under

Section 501(c)(3) of the Internal

Revenue Code for a tax exempt status;

and bonds issued by private entities that

qualify under Section 142(d) of the

Internal Revenue Code for a partially tax

exempt status (subject to only to the

alternative minimum tax). See Citicorp,

75 Fed. Res. Bull., 751 (1989) & 83 Fed.

Res. Bull. 510 (1997).

B. Federal Reserve Bank of Chicago

(Philip Jackson, Applications Officer)

230 South LaSalle Street, Chicago,

Illinois 60690-1413:

1. CITBA Financial Corporation,

Mooresville, Indiana; to acquire

Independent Bankers Life Insurance

Company of Indiana, Phoenix, Arizona,

a reinsurance subsidiary, and thereby

indirectly engage in underwriting credit

life, accident and health insurance

directly related to extensions of credit

by the banks and bank holding

companies owning stock in the

insurance agency, pursuant to §

225.28(b)(11)(i) of the Board’s

Regulation Y.

Board of Governors of the Federal Reserve

System, May 19, 1998.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 98–13788 Filed 5–21–98; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL RESERVE SYSTEM

Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Board of

Governors of the Federal Reserve

System.

TIME AND DATE: 10:00 a.m., Wednesday,

May 27, 1998.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, 20th and C

Streets, NW., Washington, DC 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments,

reassignments, and salary actions)

involving individual Federal Reserve

System employees.

2. Any matters carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Joseph R. Coyne, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.bog.frb.fed.us for an electronic

announcement that not only lists

applications, but also indicates

procedural and other information about

the meeting.

DATED: May 20, 1998.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 98–13862 Filed 5–20–98; 12:55 pm]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 98P–0160]

Determination That Cimetidine 100 mg

Tablets Were Not Withdrawn From Sale

for Reasons of Safety or Effectiveness

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) has determined

that cimetidine 100 milligram (mg)

tablets were not withdrawn from sale for

reasons of safety or effectiveness. This

determination will allow FDA to

approve abbreviated new drug

applications (ANDA’s) for drugs that

refer to cimetidine 100 mg tablets.

FOR FURTHER INFORMATION CONTACT:

Virginia G. Beakes, Center for Drug

Evaluation and Research (HFD–7), Food

and Drug Administration, 5600 Fishers

Lane, Rockville, MD 20857, 301–594–

2041.

SUPPLEMENTARY INFORMATION: In 1984,

Congress enacted the Drug Price

Competition and Patent Term

Restoration Act of 1984 (Pub. L. 98–

417)(the 1984 amendments), which

authorized the approval of duplicate

versions of drug products approved

under an ANDA procedure. ANDA

sponsors must, with certain exceptions,

show that the drug for which they are

seeking approval contains the same

active ingredient in the same strength

and dosage form as the ‘‘listed drug,’’

which is a version of the drug that was

previously approved under a new drug

application (NDA). Sponsors of ANDA’s

do not have to repeat the extensive

clinical testing otherwise necessary to

gain approval of an NDA. The only

clinical data required in an ANDA are

data to show that the drug that is the

subject of the ANDA is bioequivalent to

the listed drug.

The 1984 amendments included what

is now section 505(j)(6) of the Federal

Food, Drug, and Cosmetic Act (21 U.S.C.

355(j)(6)), which requires FDA to

publish a list of all approved drugs.

FDA publishes this list as part of the

‘‘Approved Drug Products with

Therapeutic Equivalence Evaluations,’’

which is generally known as the

‘‘Orange Book.’’ Under FDA’s

regulations, drugs are withdrawn from

the list if the agency withdraws or

suspends approval of the drug’s NDA or

ANDA for reasons of safety or

effectiveness, or if FDA determines that

the listed drug was withdrawn from sale

for reasons of safety or effectiveness (21

CFR 314.162). Regulations also provide

that the agency must make a

determination as to whether a listed

drug was withdrawn from sale for

reasons of safety or effectiveness before

an ANDA that refers to that listed drug

may be approved (§ 314.161(a)(1) (21

CFR 314.161(a)(1))). FDA may not

approve an ANDA that does not refer to

a listed drug.

In citizen petitions dated March 9,

1998 (Docket No. 98P–0160/CP 1), and

March 13, 1998 (Docket No. 98P–0160/

CP 2), submitted in accordance with 21

CFR 314.122, Apotex Corp. and

Novopharm Limited, respectively,

requested that the agency determine

whether cimetidine (Tagamet HB) 100

mg tablets were withdrawn from sale for

reasons of safety or effectiveness.

Cimetidine 100 mg tablets are the

subject of approved NDA 20–238 held

by SmithKline Beecham Consumer

Healthcare LP (SmithKline Beecham). In

1997, SmithKline Beecham withdrew

cimetidine 100 mg tablets from sale.

FDA has reviewed its records and,

under § 314.161, has determined that

cimetidine 100 mg tablets were not

withdrawn from sale for reasons of

safety or effectiveness. Accordingly, the

agency will maintain cimetidine 100 mg

tablets in the ‘‘Discontinued Drug

Product List’’ section of the Orange

Book. The ‘‘Discontinued Drug Product

List’’ delineates, among other items,

drug products that have been

discontinued from marketing for reasons

other than safety or effectiveness.

ANDA’s that refer to cimetidine 100 mg

tablets may be approved by the agency.